PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 2922 (116th)

Respond NOW Act

referredUnited States· United States Congress· EN

Introduced

22 May 2019

Last action

26 June 2019 · Referred

Status

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Sponsors

Ann Kuster, Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Scanlon, Mary Gay [D-PA-5], Rep. Pingree, Chellie [D-ME-1], Haley Stevens, Sheila Jackson Lee, Rep. Frankel, Lois [D-FL-22], David Trone, Paul Tonko, Rep. Raskin, Jamie [D-MD-8], Julia Brownley, Rep. Doggett, Lloyd [D-TX-37], Chris Pappas, Katherine Clark, Rep. Trahan, Lori [D-MA-3], Sen. Welch, Peter [D-VT], Rep. Castro, Joaquin [D-TX-20], Rep. Dingell, Debbie [D-MI-6], Donna Shalala, Gwen Moore, Jerry McNerney, Seth Moulton, Sen. Blunt Rochester, Lisa [D-DE], James McGovern, John Larson, Rep. Crow, Jason [D-CO-6], Rep. Matsui, Doris O. [D-CA-7], Robin Kelly, Rep. Barragán, Nanette Diaz [D-CA-44], Rep. Schakowsky, Janice D. [D-IL-9], Rep. Veasey, Marc A. [D-TX-33], Karen Bass, Alexander Mooney, RON KIND, Sen. Slotkin, Elissa [D-MI], Tom Malinowski, Donald Norcross

Subjects

Healthcare

Source updated

21 July 2025

Healthcare

Summary

Respond to the Needs in the Opioid War Act or the Respond NOW Act This bill establishes the Opioid Epidemic Response Fund through FY2024 to fund programs and activities addressing the opioid and substance use epidemic, including Substance Abuse and Mental Health Services Administration demonstration grants; Centers for Disease Control and Prevention surveillance, prevention, and treatment programs; Food and Drug Administration support of innovation in non-opioid and nonaddictive medical products for pain treatment; National Institutes of Health research on creating longer-lasting or faster-acting antidotes for opioid overdoses; Health Resources and Services Administration efforts to increase the availability and capacity of the behavioral health workforce; and Administration for Children and Families programs for child abuse prevention and treatment. The bill also extends funding through FY2024 for programs to help states and tribal organizations address substance use prevention and treatment, allows a practitioner to dispense narcotic drugs for maintenance treatment or detoxification treatment to an increased number of patients under specified conditions, and includes methadone treatment in Medicare coverage.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 22 May 2019

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  2. 22 May 2019

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Ways and Means, the Budget, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 22 May 2019

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 22 May 2019

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 23 May 2019

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  6. 26 June 2019

    Referred

    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.